Form 4 for ANIP ANI PHARMACEUTICALS INC
Accepted 2025-03-04 00:00:00 ET · period of report 2025-02-28 · accession 0001507496-25-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-04 | 2025-02-28 | ANIP | Rowland Thomas Andrew | SVP, HEAD - ESTABLISHED BRANDS | F - Tax | $61.89 | -627 | 45.5K | -1% | -$38.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-28 | F | D | 627 | $61.89 | 45,465 | D | — | — |